Kidney function and potassium monitoring after initiation of renin-angiotensin-aldosterone system blockade therapy and outcomes in two North American populations.

BACKGROUND: Clinical practice guidelines recommend routine kidney function and serum potassium testing within 30 days of initiating angiotensin-converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB) therapy. However, evidence is lacking about whether follow-up testing reduces th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Cardiovasc Qual Outcomes
Main Authors: Parikh, Rishi V, Nash, Danielle M, Brimble, K Scott, Markle-Reid, Maureen, Tan, Thida C, McArthur, Eric, Khoshniat-Rad, Farzien, Sood, Manish M, Zheng, Sijie, Pravoverov, Leonid, Nesrallah, Gihad E, Garg, Amit X, Go, Alan S
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7717925/
https://ncbi.nlm.nih.gov/pubmed/32873054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.119.006415
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados